Alto Neuroscience ANRO Other accrued liabilities
Other accrued liabilities at other companies
Other financials
Where this comes from
Reported directly by Alto Neuroscience in its filing.
Tagged under the XBRL concept us-gaap:OtherAccruedLiabilitiesCurrent.
The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Alto Neuroscience's other accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Alto Neuroscience's other accrued liabilities?
- Alto Neuroscience (ANRO) reported other accrued liabilities of $1.05M in Q1 2026.
- How has Alto Neuroscience's other accrued liabilities changed year-over-year?
- Alto Neuroscience's other accrued liabilities increased by 49.5% year-over-year, from $701K to $1.05M.
- What is the long-term trend for Alto Neuroscience's other accrued liabilities?
- Over 2 years (2023 to 2025), Alto Neuroscience's other accrued liabilities has grown at a 7.8% compound annual growth rate (CAGR), from $515K to $599K.